Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 13/20 | 0.70 |
| ▸ | GSK3B | P49841 | 1/20 | 0.67 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.65 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.65 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.65 |
| ▸ | FGFR4 | P22455 | 2/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4488994 | 0.91 | HDAC6 (0.70) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4485554 | 0.88 | GSK3B (0.66) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4500708 | 0.87 | GSK3B (0.67) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL30206851 | 0.87 | FGFR4 (0.74) | HDAC6FGFR1FGFR2FGFR3FGFR4 | |
| SCHEMBL4500986 | 0.86 | HDAC6 (0.76) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4495002 | 0.86 | GSK3B (0.69) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4496487 | 0.85 | GSK3B (0.67) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4483610 | 0.84 | GSK3B (0.64) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4491911 | 0.84 | GSK3B (0.72) | HDAC6GSK3BFGFR1FGFR2FGFR3 | |
| SCHEMBL4485588 | 0.84 | HDAC6 (0.63) | HDAC6GSK3BFGFR1FGFR2FGFR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7632854-B2 | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | PFIZER ITALIA S.R.L. (IT) | 2009-12-15 | — | — | US | claimed |